Andere Sprachen Verona Pharma plc

Aktien

A2N39N

US9250501064

VRNA

Realtime-Estimate Cboe BZX Andere Börsenplätze 19:00:10 23.04.2024			% 5 Tage	% 1. Jan.
15.77 ^USD	+0.32%		-2.84%	-20.82%

22.04.	Europäische Aktien werden in den USA als amerikanische Depositary Receipts gehandelt und erholen sich im Montagshandel	MT
16.04.	Europäische Aktien, die in den USA als American Depositary Receipts gehandelt werden, geben im Dienstagshandel nach	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	22.04.
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	16.04.
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	05.04.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	04.04.
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	26.03.
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading	25.03.
Verona Pharma : Notice and Proxy Statement AGM 2024	21.03.
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	21.03.
Verona Pharma : Notice and Proxy Statement AGM 2024	20.03.
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	20.03.
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	14.03.
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	13.03.
Andrew Fisher Joins Verona Pharma as General Counsel	04.03.
Verona Pharma plc Announces Management Changes	04.03.
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat	01.03.
Verona Pharma Shares Rise After Narrower-Than-Expected Q4 Loss	29.02.
Verona Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29.02.
Verona Pharma plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29.02.
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading	27.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Verona Pharma plc

Aktien

A2N39N

US9250501064

VRNA

Andere Sprachen

Filter